发明名称 Use of anatabine to treat inflammation and methods of synthesizing anatabine
摘要 H:/xd/Interwoven/NRPortbl/DCC/SXD/I33562121.docx-8/03/2017 Pharmaceutical compositions comprising an isolated form of anatabine or a salt thereof can be used to treat disorders comprising an inflammatory component, including chronic, low level inflammation. In another aspect, methods for the synthetic preparation of anatabine involve reacting benzophenoneimine with 3-aminomethyl pyridine to form benzylhydrylidene pyridin-3-yl-methyl-amine. The benzylhydrylidene-pyridin-3-yl-methyl-amine is treated with a non-nucleophilic base and a dielectrophile, such as cis- 1,4-dichloro-2-butene, followed by acidification, then basification, to provide anatabine. 100 ______ E_ RACEMIO MIXTURE )S (S-(-)-ANATABINE Lu co40 0 10 100 200 400 600 800 1000 DOSE (pg/mL)
申请公布号 AU2017201593(A1) 申请公布日期 2017.03.30
申请号 AU20170201593 申请日期 2017.03.08
申请人 Rock Creek Pharmaceuticals, Inc. 发明人 Williams, Jonnie R.;Puthiaparampil, Tom Thomas;David, Thomas Kanathkunn;Raju, Muppala Sarveswara
分类号 A61K31/4458;A61P29/00 主分类号 A61K31/4458
代理机构 代理人
主权项
地址